Cargando…
AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis
SIMPLE SUMMARY: Skin cancer, such as melanoma, is often treatable but becomes deadly when it expands to other places in the body, a process called metastasis. While many current drugs target melanoma tumor growth, no drugs yet exist to specifically prevent metastasis. Improving treatment outcomes, t...
Autores principales: | McRee, Siobhan K., Bayer, Abraham L., Pietruska, Jodie, Tsichlis, Philip N., Hinds, Philip W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605002/ https://www.ncbi.nlm.nih.gov/pubmed/37894325 http://dx.doi.org/10.3390/cancers15204958 |
Ejemplares similares
-
AKT1 Is Required for a Complete Palbociclib-Induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma
por: Bayer, Abraham L., et al.
Publicado: (2022) -
Senescence and tumor suppression
por: Hinds, Philip, et al.
Publicado: (2017) -
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
por: Sundstrøm, Terje, et al.
Publicado: (2019) -
Novel combination therapies for BRAF-mutant melanoma
por: McArthur, Grant A
Publicado: (2015) -
Optimizing the treatment of BRAF mutant melanoma
por: Settleman, Jeff
Publicado: (2014)